Chromosome17 (Chr17) is the second most gene-dense chromosome in the human genome [ 1], containing many genes central to breast cancer development and progression, including oncogenes (HER2, TOP2A, STARD3, TAU), tumor suppressor genes (TP53, BRCA1, HIC-1) and DNA double-strand break repair genes (RDM1) [ 2– 7].
This amplicon contains many candidate genes for breast cancer susceptibility.
Breast tissue contains many lobes (segments) and these contain lobules which are groups of breast cells.
For example, studies have shown that breast-fed infants acquire a more desirable intestinal flora than formula-fed infants, since breast milk contains many antimicrobial products and factors that promote the colonization of helpful bacteria in the infant intestine [3], [34], [35].
The results demonstrate that breast milk contains many pollutants.
Many general presentations contained many principles that apply to breast cancer development and treatment.
Breast milk contains many bioactive molecules, including SIgA, which could potentially regulate the composition of the gut microbiota and the host response to these microbes.
The over-representation of other transporters may also be advantageous to the microbes in the infant intestine because breast milk contains many other essential nutrients such as amino acids, long-chain fatty acids, nucleotides, vitamins, and minerals in a readily available form.
Normal breast tissue typically does not contain many of the small-molecule metabolites, such as amino acids, glycolytic intermediates and choline-containing metabolites, found in breast tumors.
The literature contains many single institution reports of the use of breast MRI for monitoring tumour response or predicting tumour extent prior to surgery.
Traditional breast cancer (BrCa) bone metastasis models contain many limitations with regards to controllability, reproducibility and flexibility of design.
